Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine Trigger Point Injections for Post-Surgery Neuropathic Pain
NCT04764045Unknown
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Nov 2019
- Primary completion
- May 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial in neuropathic pain comparing Ropivacaine with Placebo (2 arms). Primary endpoint: Change in worst pain in rest and in activity at 30 minutes. Status: unknown.
02
Drugs
ropivacaine
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT04764045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04764045.